Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of mRNA SARS-CoV-2 Vaccine in Thai Children 6 Months–4 Years
TCTR20220927003Phase 2Completed
- Sponsor
- National Vaccine Institute
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 2 trial in coronavirus disease 2019 (COVID-19), sponsored by National Vaccine Institute. Started Oct 2022; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20220927003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220927003.